# An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

> **NCT01260480** · PHASE2 · UNKNOWN · sponsor: **Aposense Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Head and Neck Neoplasms

## Interventions

- **OTHER:** [18F]-ML-10 in conjunction with PET imaging

## Key facts

- **NCT ID:** NCT01260480
- **Lead sponsor:** Aposense Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2012-02
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260480, "An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01260480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*